The GALAD score performs better than AFP in hepatocellular carcinoma screening: a single-centre, case-control study in Malaysia

Journal

Clinical and Experimental Hepatology

Year

2025

Materials & Methods

A single-centre, case control study recruited newly diagnosed HCC and cirrhotic patients. Serum biomarkers were quantified using a microfluidic-based automated immunoanalyzer. The diagnostic ability of AFP, AFP-L3, PIVKA-II and GALAD was assessed using receiver operating characteristic curve (ROC) and corresponding area under the curve (AUC) analysis.

Results

Among the 44 HCC cases, GALAD score achieved the highest AUC value of 0.94 (95% confidence interval [CI]: 0.90-0.98, p < 0.0001) significantly surpassing AFP (0.89), AFP-L3 (0.84) and PIVKA-II (0.88). The GALAD score demonstrated 84.1% sensitivity and 93.8% specificity at the standard cut-off (–0.63) and 88.6%/92.2% at its best cut-off (–1.035) for detecting any stage of HCC, outperforming AFP (79.5%/92.2%), AFP-L3 (59.1%/94.9%) and PIVKA-II (79.5%/84.9%). The sensitivity of the GALAD score was 100% in earlystage HCC (BCLC0/A).

Conclusion

GALAD outperformed conventional biomarkers, facilitating early detection, improved treatment options and ultimately a higher survival rate for HCC patients.

Resources and Links

Phone Number: +603 2781 4519 / +603 2781 4520

https://www.termedia.pl/The-GALAD-score-performs-better-than-AFP-in-hepatocellular-carcinoma-screening-a-single-centre-case-control-study-in-Malaysia,80,55715,0,1.html

Share the Page

Information

Consultant Name

Dr Wong Zhiqin

For general questions about clinical trials

Phone Number: +603 2781 4519 / +603 2781 4520

Email

[email protected]

I would like to be a part of tomorrow's breakthrough

Clinical trials are part of research studies involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions. They are critical to the advancement of medicine and improving patient health. Participating in clinical trials offers patients the opportunity to try new and effective treatments that could potentially improve their condition while taking part in vital research that can benefit many future patients.

In Pantai Hospital Kuala Lumpur, clinical trials are carried out under our Clinical Research team.

If you would like to participate in any of our clinical trials or would like to know, please provide your information below and we will be in touch with you: